Protect I results support Impella use
This article was originally published in Clinica
Executive Summary
The Impella 2.5 heart pump developed by Abiomed can safely support patients during high-risk percutaneous coronary intervention (PCI) procedures, according to data presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, DC.